DekaBank Deutsche Girozentrale »

Adma Biologics shares owned by DekaBank Deutsche Girozentrale

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by DekaBank Deutsche Girozentrale from 13F filings

Historical chart of DekaBank Deutsche Girozentrale investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by DekaBank Deutsche Girozentrale consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by DekaBank Deutsche Girozentrale

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.6M 236k 6.73
2023-12-31 $1.1M 236k 4.52
2023-09-30 $58k 16k 3.59

More positions owned by DekaBank Deutsche Girozentrale

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Apple (AAPL)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Procter & Gamble Company (PG)
Merck & Co (MRK)
Johnson & Johnson (JNJ)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Mastercard Incorporated Cl A (MA)
Accenture Plc Ireland Shs Class A (ACN)
Abbvie (ABBV)

View all positions for DekaBank Deutsche Girozentrale

Top funds holding Adma Biologics

Vanguard Group
D. E. Shaw & Co
Perceptive Advisors
AWM Investment Company
Dimensional Fund Advisors
Millennium Management
Assenagon Asset Management
Two Sigma Investments
Deutsche Bank Aktiengesellschaft
Two Sigma Advisers
Oberweis Asset Management
Goldman Sachs Group
Charles Schwab Investment Management
Bank of America Corporation
Tang Capital Management

View all funds holding Adma Biologics